AMELY and hepatocellular carcinoma: In summary, the biological processes and occurrence numbers of GO in HCC tissue with high expression (fold change ≥2) of AMELY-activated upstream regulation network were compared with those of the corresponding non-tumor hepatitis/cirrhotic tissues with low expression of the activated network.